|
|
Volumn 7, Issue 2, 2005, Pages 127-128
|
|
New hope for systemic sclerosis patients with digital ulcers.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BOSENTAN;
ENDOTHELIN RECEPTOR;
SULFONAMIDE;
ARTICLE;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG ANTAGONISM;
FINGER;
HAND DISEASE;
HUMAN;
LIVER DISEASE;
LOCALIZED SCLERODERMA;
MULTICENTER STUDY;
ORAL DRUG ADMINISTRATION;
RANDOMIZED CONTROLLED TRIAL;
SKIN DISEASE;
SKIN ULCER;
SYSTEMIC SCLEROSIS;
TOE;
TREATMENT OUTCOME;
ADMINISTRATION, ORAL;
DOUBLE-BLIND METHOD;
FINGERS;
FOOT DERMATOSES;
HAND DERMATOSES;
HUMANS;
LIVER DISEASES;
RECEPTORS, ENDOTHELIN;
SCLERODERMA, LOCALIZED;
SCLERODERMA, SYSTEMIC;
SKIN ULCER;
SULFONAMIDES;
TOES;
TREATMENT OUTCOME;
|
|
EID: 23644438053
PISSN: 15233774
EISSN: None
Source Type: Journal
DOI: 10.1007/s11926-005-0064-1 Document Type: Article |
|
Times cited : (5)
|
|
References (0)
|
